Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Short Interest Update

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 1,250,000 shares, a growth of 31.2% from the October 15th total of 952,600 shares. Currently, 6.4% of the company’s shares are sold short. Based on an […]

Leave a Reply

Your email address will not be published.

Previous post South Street Advisors LLC Trims Stock Position in RTX Co. (NYSE:RTX)
Next post Walt Disney (NYSE:DIS) Price Target Raised to $130.00